Richard Scott Struthers - 16 Jun 2023 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Signature
/s/ Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
16 Jun 2023
Transactions value $
-$1,040,500
Form type
4
Filing time
21 Jun 2023, 17:27:50 UTC
Previous filing
17 Mar 2023
Next filing
13 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Sale -$1,040,500 -50,000 -6.8% $20.81 680,805 16 Jun 2023 By Family Trust 1
holding CRNX Common Stock 125,522 16 Jun 2023 Direct
holding CRNX Common Stock 1,000 16 Jun 2023 By Spouse
holding CRNX Common Stock 90,000 16 Jun 2023 By Family Trust 2
holding CRNX Common Stock 90,000 16 Jun 2023 By Family Trust 3
holding CRNX Common Stock 90,000 16 Jun 2023 By Family Trust 4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).